Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
John R Ford, M.D.
Family Practice · EUGENE, OR · NPI 1396749859
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 643 | 278 |
| Lisinopril | Lisinopril | 471 | 197 |
| Levothyroxine Sodium | Levothyroxine Sodium | 363 | 150 |
| Amlodipine Besylate | Amlodipine Besylate | 292 | 126 |
| Gabapentin | Gabapentin | 282 | 100 |
| Omeprazole | Omeprazole | 271 | 105 |
| Losartan Potassium | Losartan Potassium | 235 | 100 |
| Tamsulosin Hcl | Tamsulosin Hcl | 193 | 73 |
| Metformin Hcl Er | Metformin Hcl | 170 | 72 |
| Trazodone Hcl | Trazodone Hcl | 159 | 67 |
| Eliquis | Apixaban | 157 | 50 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 154 | 67 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 137 | 54 |
| Oxycodone Hcl | Oxycodone Hcl | 126 | 50 |
| Simvastatin | Simvastatin | 125 | 58 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 112 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 111 | 45 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 110 | 57 |
| Pravastatin Sodium | Pravastatin Sodium | 109 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 105 | 40 |
| Furosemide | Furosemide | 103 | 41 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 100 | 37 |
| Metformin Hcl | Metformin Hcl | 100 | 43 |
| Sertraline Hcl | Sertraline Hcl | 97 | 36 |
| Montelukast Sodium | Montelukast Sodium | 93 | 40 |
| Tramadol Hcl | Tramadol Hcl | 88 | 37 |
| Allopurinol | Allopurinol | 87 | 33 |
| Lovastatin | Lovastatin | 86 | 38 |
| Alendronate Sodium | Alendronate Sodium | 83 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 83 | 33 |
| Meloxicam | Meloxicam | 77 | 27 |
| Potassium Chloride | Potassium Chloride | 77 | 37 |
| Bupropion Xl | Bupropion Hcl | 76 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 76 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 33 |
| Spironolactone | Spironolactone | 69 | 24 |
| Carvedilol | Carvedilol | 67 | 31 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 67 | 21 |
| Irbesartan | Irbesartan | 60 | 29 |
| Chlorthalidone | Chlorthalidone | 59 | 32 |
| Estradiol | Estradiol | 58 | 24 |
| Memantine Hcl | Memantine Hcl | 58 | 11 |
| Glimepiride | Glimepiride | 56 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 53 | 21 |
| Ozempic | Semaglutide | 53 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 52 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 52 | 22 |
| Alprazolam | Alprazolam | 51 | 27 |
| Propranolol Hcl | Propranolol Hcl | 51 | 23 |
| Warfarin Sodium | Warfarin Sodium | 51 | 25 |
| Pregabalin | Pregabalin | 50 | 19 |
| Atenolol | Atenolol | 49 | 22 |
| Torsemide | Torsemide | 49 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 48 | 17 |
| Mirtazapine | Mirtazapine | 47 | 13 |
| Jardiance | Empagliflozin | 46 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 12 |
| Acyclovir | Acyclovir | 43 | 19 |
| Famotidine | Famotidine | 41 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 28 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 38 | 14 |
| Testosterone Cypionate | Testosterone Cypionate | 38 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Ondansetron Odt | Ondansetron | 36 | 14 |
| Lorazepam | Lorazepam | 35 | 19 |
| Topiramate | Topiramate | 35 | suppressed |
| Valsartan | Valsartan | 35 | 15 |
| Methocarbamol | Methocarbamol | 34 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | 14 |
| Buprenorphine Hcl | Buprenorphine Hcl | 32 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 32 | 11 |
| Donepezil Hcl | Donepezil Hcl | 32 | 11 |
| Synthroid | Levothyroxine Sodium | 32 | 13 |
| Trulicity | Dulaglutide | 32 | 13 |
| Baclofen | Baclofen | 31 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | 14 |
| Finasteride | Finasteride | 30 | 15 |
| Ezetimibe | Ezetimibe | 29 | 14 |
| Ibuprofen | Ibuprofen | 29 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 26 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Lactulose | Lactulose | 25 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | 12 |
| Buspirone Hcl | Buspirone Hcl | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 11 |
| Clonazepam | Clonazepam | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 18 | suppressed |
| Xarelto | Rivaroxaban | 18 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Prednisone | Prednisone | 14 | 11 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Testosterone | Testosterone | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error